ExeVir Bio is a young and dynamic clinical stage company, developing single-domain antibody-based therapies. Our lead candidate XVR011 is in accelerated development as a COVID-19 therapeutic.
ExeVir Bio is led by a team of experts that combines international biotech and pharma experience with a successful track record of developing and bringing products to market.
We are seeking a highly motivated (Senior) Scientist with a strong background in protein engineering and a Ph.D. in the field of Molecular Biology, Structural Biology, Virology or Bio-engineering.
The scientist will be responsible for managing the discovery and preclinical development, as well as supporting the R&D of our pipeline candidate(s) with the aim to move the pipeline candidate(s) towards licensure. The person in this role will lead preclinical studies and activities related to antibody discovery as well as characterization of the pharmacodynamic, pharmacokinetic and toxicological properties required to progress pipeline candidate compounds to Clinical Candidate Declaration and subsequently support the clinical development.
The role requires a strong background in antibody discovery, strong protein engineering, structural biology and experience in study design, protocol writing, data evaluation, and the preparation of study reports and other written documentation of preclinical data.
This position offers the opportunity to contribute scientific knowledge, project and people management skills to a collaborative and dynamic team in a small start-up company. Efficiency, enthusiasm, and reliability are a must to thrive in this fast-paced, challenging environment where all must take a hands-on approach to get things done.
Main responsibilities:
Reports to: Head of Preclinical Development
Lorane Molineaux
+32 478 50 77 03
Submit your HR challenge to us. Together we look at how we can help you.